Psyence Biomedical Ltd. Gains 66.14%
Fri, Mar 08, 2024 at 07:19 PM
Psyence Biomedical Ltd. (PBM:NASDAQ) soared at $2.11, a gain of 66.1%. On Fri, Mar 08, 2024, PBM:NASDAQ touched a New 2-Week High of $2.11. The stock got featured on our News Catalysts scanner on Wed, Mar 06, 2024 at 08:39 AM in the 'BIOTECH' category. From Mon, Feb 26, 2024, the stock recorded 66.67% Up Days and 60.00% Green Days
The stock spiked on Fri, Mar 08, 2024 at $4.31 with a volume of 149M+.
About Psyence Biomedical Ltd. (PBM:NASDAQ)
Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa.
Top 10 Gainers:
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
- Safe and Green Development Corporation (SGD:NASDAQ), 88.16%
- MIRA Pharmaceuticals Inc. (MIRA:NASDAQ), 71.4%
- Semilux International Ltd. (SELX:NASDAQ), 69%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 66.14%
- XBP Europe Holdings Inc. (XBP:NASDAQ), 61.61%
- Edoc Acquisition Corp. (ADOC:NASDAQ), 36.25%
- NWTN Inc. (NWTN:NASDAQ), 35.9%
- reAlpha Tech Corp. (AIRE:NASDAQ), 35.2%
- Trxade Group, Inc. (MEDS:NASDAQ), 34.37%